Since CAT -1 is a membrane protein, specific monoclonal antibodies can be used to neutralize cat-1 and inhibit the uptake of arginine by CRC cells, so as to achieve the purpose of tumor treatment. The gene discussed is GIT1; the disease is colorectal carcinoma.